Leica Biosystems Imaging, Inc.

FDA Regulatory Profile

Leica Biosystems Imaging, Inc. appears in FDA public data with 2 recalls, 5 510(k) clearances, 2 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-0046-2020, Class II) was initiated on Dec 10, 2018. Its most recent 510(k) clearance was granted on Aug 7, 2026.

Summary

Total Recalls
2
510(k) Clearances
5
Inspections
2
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-0046-2020Class IIAperio CS2 CE IVD scanner instrument, scanner part #23CS100CE.Dec 10, 2018
Z-1152-2014Class IIHER2 Image Analysis Manual Read of HER2 Digital Slides ER/PR Image Analysis IHC PR Breast Tissue Feb 7, 2014

Recent 510(k) Clearances

K-NumberDeviceDate
K253561Aperio iQC DX SoftwareAug 7, 2026
K253554Aperio GT 450 DX; Aperio GT 180 DXAug 7, 2026
K232202Aperio GT 450 DXApr 16, 2024
K190332Aperio AT2 DX SystemMay 20, 2019
K141109APERIO EPATHOLOGY EIHC IVD SYSTEMJul 29, 2014